Multiple Sclerosis and Aging

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research MS and aging.

May 7, 2020
Open Access

Multiple sclerosis and related challenges to young women's health: Canadian expert review

Neurodegenerative Disease Management
Galina VorobeychikAshley Cox
June 6, 2020
Open Access

Principal component analysis of blood microRNA datasets facilitates diagnosis of diverse diseases

PloS One
Stacy L SellHelen L Hellmich
September 6, 2020
Review
Open Access

CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders

Pharmaceuticals
Mariya IvanovskaMichael Maes
August 5, 2020
Review

The molecular anatomy and functions of the choroid plexus in healthy and diseased brain

Biochimica Et Biophysica Acta. Biomembranes
Ingrid KratzerHelen Stolp
May 29, 2020
Preprint
Open Access

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis through Immunophenotyping

MedRxiv : the Preprint Server for Health Sciences
P. HannikainenBibiana Bielekova
June 2, 2020
Open Access

A Systematic Review of the Neurocognitive Effects of Cannabis Use in Older Adults

Current Addiction Reports
Emmi P ScottAndreana Benitez
June 27, 2020
Preprint

Fast automatic segmentation of thalamic nuclei from MP2RAGE acquisition at 7 Tesla

ArXiv
Ritobrato DattaManojkumar Saranathan
June 23, 2020

Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis

Multiple Sclerosis : Clinical and Laboratory Research
Lisa GlukhovskyJames F Sumowski
May 28, 2020
Review

Impact of Age on Multiple Sclerosis Disease Activity and Progression

Current Neurology and Neuroscience Reports
Burcu Zeydan, Orhun H Kantarci
June 25, 2020
Review

Family planning in multiple sclerosis: conception, pregnancy, breastfeeding

Ideggyógyászati szemle
Csilla Rózsa
September 2, 2020
Review
Open Access

Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism

Nutrients
Tanja Grubić Kezele, Božena Ćurko-Cofek
April 25, 2020
Open Access

Contribution of normal aging to brain atrophy in MS

Neurology. Neuroimmunology and Neuroinflammation
Christina J AzevedoDaniel Pelletier
July 14, 2020
Review
Open Access

Sex effects across the lifespan in women with multiple sclerosis

Therapeutic Advances in Neurological Disorders
Kristen M KryskoKerstin Hellwig
June 6, 2020
Open Access

Thirty years of translational research in Mobility Medicine: Collection of abstracts of the 2020 Padua Muscle Days

European Journal of Translational Myology
Ugo Carraro
May 12, 2020
Open Access

Shared Regulatory Pathways Reveal Novel Genetic Correlations Between Grip Strength and Neuromuscular Disorders

Frontiers in Genetics
Sreemol GokuladhasJustin O'Sullivan
August 28, 2020

The Ubiquitin System and A20: Implications in Health and Disease

Journal of Dental Research
E C Mooney, S E Sahingur
April 15, 2020

Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy

Annals of Neurology
Elias S SotirchosInternational Multiple Sclerosis Visual System (IMSVISUAL) Consortium
August 8, 2020

Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis

Drugs & Aging
Simone PagheraLuisa Imberti
July 23, 2020
Review
Open Access

Aging, Cellular Senescence, and Progressive Multiple Sclerosis

Frontiers in Cellular Neuroscience
Dimitrios PapadopoulosRichard S Nicholas

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-and-aging/cce082e1-73b4-435d-b61a-42ded6bef250